Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
Abstract
Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier.
2 . The composition in accordance to claim 1 wherein the compound is administered between about 2.5 mg to about 10 mg of compound per kilogram of subject body weight.
3 . The composition in accordance to claim 1 , wherein the therapeutically effective amount of pterostilbene is administered via a diet of Vaccinium berries.
4 . The composition in accordance with claim 3 , wherein the Vaccinium berries are blueberries.
5 . A method for treating oxidative stress, the method comprising administering a therapeutically effective amount of a substantially pure compound of pterostilbene, wherein oxidative stress for a subject is reduced.
6 . The method as recited in claim 5 wherein the therapeutic effective amount is between about 2.5 mg to about 10 mg of compound per kilogram of subject body weight.
7 . The method as recited in claim 5 wherein the compound increases subject acetylcholine receptor activity.
8 . The method as recited in claim 5 wherein dopamine release does not decrease upon subjecting the subject to an oxidative stressor.
9 . The method as recited in claim 5 wherein pterostilbene is administered via a diet of Vaccinium berries.
10 . The method as recited in claim 9 wherein the Vaccinium berries are blueberries.
11 . The method as recited in claim 5 wherein pterostilbene increases calcium buffering ability of muscarinic receptor subtypes.
12 . The method as recited in claim 11 wherein the muscarinic subtype is M1.
13 . A method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject is increases.
14 . The method as recited in claim 13 wherein the therapeutic effective amount is of pterostilbene is about 10 mg of compound per kilogram of subject body weight.
15 . The method of claim 13 wherein pterostilbene is administered with a pharmaceutical earner.
16 . The method of claim 13 wherein pterostilbene is administered with a nutraceutical carrier.
17 . The method of claim 5 wherein pterostilbene is derived from botanical plants.Join the waitlist — get patent alerts
Track US2009069444A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.